Abstract
High 21-gene recurrence score (RS) is associated with an impaired prognosis in patients with HR-positive/HER2-negative early breast cancer (EBC) and predictive of response to adjuvant chemotherapy. Detection of disseminated tumor cells (DTCs) in the bone marrow is a surrogate of minimal residual disease and of prognostic value. The aim of this study was to compare DTC detection with the 21-gene RS. DTCs were identified in bone marrow aspirates of HR-positive/HER2-negative EBC patients by immunocytochemistry (pancytokeratin antibody A45-B/B3) and cytomorphology at primary surgery. The 21-gene RS was assessed in paraffin-embedded tumor tissue samples using Oncotype DX (Genomic Health). A total of 114 patients were included in this study. DTCs were detected in 13 of these (11 %). Of the women with a low RS (<18), 5/75 (7 %) were DTC positive. Of the women with an intermediate/high RS (≥18), 8/39 (21 %) were DTC positive (p = 0.03, Chi-squared test). The median RS in DTC-negative patients was significantly lower as compared to DTC-positive patients (15 vs. 20, p = 0.04, Mann-Whitney U test). In conclusion, detection of DTCs in patients with EBC is associated with high 21-gene recurrence score. These findings are meaningful for furt...Continue Reading
References
Dec 14, 2004·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Aug 27, 2005·The New England Journal of Medicine·Stephan BraunKlaus Pantel
May 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soonmyung PaikNorman Wolmark
Jul 29, 2006·Cancer·Tanja FehmErich Solomayer
Feb 21, 2009·The New England Journal of Medicine·Christos Sotiriou, Lajos Pusztai
Mar 25, 2009·Nature Reviews. Cancer·Christoph A Klein
Dec 17, 2009·The Lancet Oncology·Kathy S AlbainUNKNOWN Breast Cancer Intergroup of North America
Jan 1, 1999·Cytotherapy·E BorgenK Pantel
Dec 25, 2012·Annals of Surgical Oncology·Christoph DomschkeFlorian Schuetz
Oct 9, 2013·Breast Cancer Research : BCR·Andreas Daniel HartkopfTanja Fehm
Mar 5, 2014·Breast Cancer Research and Treatment·Malgorzata BanysTanja Fehm
Mar 22, 2014·Molecular and Clinical Oncology·Bahriye AktasSabine Kasimir-Bauer
Aug 7, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andreas D HartkopfDiethelm Wallwiener
Apr 8, 2015·Breast Cancer Research : BCR·Balázs GyőrffyLajos Pusztai
Aug 21, 2015·JAMA Oncology·Steven A NarodPing Sun
Oct 16, 2015·Annals of Surgical Oncology·Stefan StefanovicChristoph Domschke
Citations
Jan 29, 2018·Breast Cancer Research and Treatment·Vincent P WalterAndreas D Hartkopf
Sep 6, 2020·Breast Cancer Research and Treatment·Puneet SinghAnthony Lucci
Sep 14, 2018·NPJ Breast Cancer·Mark Jesus M MagbanuaJohn W Park
Nov 23, 2019·BMC Cancer·Kjersti TjensvollBjørnar Gilje
Jul 16, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andreas D HartkopfKlaus Pantel